 Okay. Why don't I call to order the 69th meeting of the National Advisory Council for Human Genome Research. Thank you all for coming. It's great to see you all again. I'll turn this over to Rudy for a few business items. All right. So good morning, everyone. Let me remind you that the open session of the council meeting is being videocast live and will be archived. And before we get into our regular business, I'm going to turn the floor back to Eric. He has some words for our parting council members. Right. So this is a bittersweet council meeting every September because it means we are bidding farewell to a number of our council members who have served their full time, shall we say? So in some ways it's sort of parole month, if you will. We let them out on work release now. But they have done their duty, if you will. They've done their service to the institute, to the NIH, and in some ways to the nation. So we like to always acknowledge our outgoing council members with those being this is their last council meeting. I would like to probably make a couple other remarks about this group in particular because there is a certain novelty associated with this cohort of council members. First thing to say is that they've served the institute and the NIH at what truly has been a profoundly difficult time. On the one hand, they are here to help us develop our plan for genomics, which probably is the hottest of the hottest in terms of biomedical research. But you're doing it at a time where I think many acknowledges one of the worst budgetary circumstances biomedical research has seen at least in recent years, with the sequester just being the last of a series of declining budgets where things are just profoundly painful and that has made it incredibly important to have wise advisors telling us what their thoughts are as we try to navigate this very difficult circumstance. I'd also point out at the same time that was happening, the council had to deal with a newbie institute director because I think, I don't know precisely, it was either shortly after, I don't know if you're already on council, maybe you guys could remind me, if you were on council when I became director, do you become on council immediately after I became director? I can't exactly remember which. Right after I became director. But I was a rookie then and still a newbie having just had the job since December of 2009. So you had a break me in in many ways, but it also gave us an opportunity and we've talked about this in many venues and will continue to as I think even the way we've conducted these council meetings and even the way we've engaged council has changed substantially over the last three to four years in a very constructive way. And it's not to say that previously there wasn't constructive interaction with council, I just think it's a different era, a different era with respect to my leadership of the institute and the style with which I'm leading the institute, but also you saw a major reorganization of the institute take place and a lot of leadership transitions and every one of those things came in consultation with you, especially the group that are graduating here today. So I think the way we run council meetings, I think the way we engage council has really substantially improved over the term of those of you who are departing and it's a credit to many of you that we've really listened to your advice and I think have done a lot of things that has made the value of these council meetings even greater. So as a group, I thank you and I will also say and I already know it's true is that the council members that are on that are not at the end of their term, I think very much are also contributing that spirit, they see very much that we are very receptive to how to engage council and how best to sort of navigate these difficult times, but also exciting times scientifically and so I think you've also said a good example that has really, I think, made this a terrific group to interact with. So we pay you so much money for your service that I'm sure we don't need to do anything more than just say thank you, but because we don't pay you so much for your service, we like to do a little bit of additional expression of our gratitude and so as is now the custom, we have departing gifts. You want to pull one out, Rudy, just so they can see, for those who don't know this, this is designed by the Institute's graphics artist, now just flip it open, Daryl Asia, who makes these beautiful glass, designed these beautiful glass, looks like the Washington Monument, but it has the double helix right in there and it's also engraved with your name and your time of service. So I'm going to ask Rudy to go around and give you, I think you even got a piece of paper on top of that, yes. Yes, you get, yes, right, I think, so, so with that let me, and I'm going to ask Rudy to go around the table and give it to our one, two, three, four, five departing members, starting with Ross Hardison, who is probably one of the most congenial people you ever work with, whether he's a grantee or an advisor, his guidance on all of our really, his very insightful advice he's given us over the years about data production and functional genomics projects. Our quintessential biologist and geneticist is David Kingsley, who never loses sight of the big picture. I think David has given us many good ideas over his term on the council, so thank you, David. A long-standing member and leader of the ELSI research community, Pamela Sankar, has provided an excellent leadership and insights about ELSI research projects and genomics and society portfolio. She's also been sort of the founding chair of our genomics and society working group of council. David Williams has been instrumental and he's brought his knowledge and his perspective on minority health issues as well as his input on many ethical issues that we now must address as genomic technologies will be implemented. Thank you, David. And last but not least, a terrific St. Louison and St. Louis baseball cardinal fan, Rick Wilson, brings an important perspective of large-scale sequencing centers, really dealing with the front line of this rapid evolving genomics landscape, and really helping us keep us thinking clearly about many of the technological innovations that we have to deal with, especially as we apply them on a large scale. So thank you, Rick, for your service. I was also told to remind you that just because we bid you farewell from this group that we have this incredible ability of retaining phone numbers and email addresses, and that it would not be surprising if groups like, oh, I don't know, the NHGRI review branch or others like that would welcome you back to help with your peer review expertise once you go off of council's role. So don't be surprised if you continue to hear from us in various ways. So again, thank you as a group. And that leads to some introductions that I think Rudy's going to give. All right. We have several new employees at NHGRI. June and July are the months where we turn over a lot of program analysts. So there's several new ones that I want to introduce to the council. When I call your name, would you please stand so the council members can identify you? Shannon Bello. Shannon works on the protein capture common fund project and is part of Team Sequence, working predominantly on the large-scale data sequencing and analysis groups. Katherine Crawford. Katherine goes by Katie, and she works on the cancer genome atlas and TCGA and the clinical sequencing exploratory research or CSER programs. Leigh Finnegan. Leigh works on BD2K and the broader NHGRI informatics portfolio of grants. Brandon Floyd. Brandon is involved in all of the data access committees that NHGRI helps to manage, and he also participates in the population tracking activities that we report on to council. Pritha Nandi. Pritha splits her time between the encyclopedia of DNA elements and code and clinically relevant variant resource CRVR projects. Queen Nguyen, not with us this morning. Queen works on all things related to H3 Africa. Jacqueline Odgess. Jacqueline works on Emerge, Page, and the newborn sequencing programs, and you can call her Jackie and live to tell. Mr. Shane Clark. Shane is a program specialist, works in the division of genomic medicine and is probably involved in more projects than I can enumerate this morning. Thank you, Shane. We have two new program assistants, both of whom work in the division of genome sciences, Amalia Sobalvaro. Not here. Baha No. You'll see them in another venue then. Okay, from the division of policy, communications, and education. Renate Abramson. Renate is a program analyst working in the policy and program analysis, or PBA branch. Kate Saylor. Kate is a health policy analyst, also working in PBAB. And Jonathan Bailey. Probably in the back room, right? Jonathan's a graphic artist, works in the communication and public liaison branch. Okay, I'd like to welcome the council liaisons with us today. Joe McInerney from ASHG. Hi, Joe. Rhonda Schoenberg from the National Society of Genetic Counselors. Rhonda. And Judith Beckendorf from the American College of Medical Genetics and Genomics. Hi, Judith. We have several visitors today at the council in person. Apparently, there's a tour bus from Ohio State University that came. Lori Lapiema, Zhao Liang, Rami Alavan, and Lonnie Welch, all from Ohio State. There's a Sarah Beachy from the Institute of Medicine. And Rachel Levinson from Arizona State University is also joining us. We also have half of the incoming class. We bid adieu to several people this morning. You will have replacements. And joining us today, Shanita Hughes-Halbert. Shanita is professor and holds the AT&T Endowed Chair in the Department of Psychiatry and Behavioral Sciences at the Hollings Cancer Center at the Medical University of South Carolina. And Dr. Martin Kreitman is professor in the Department of Ecology and Evolution at the University of Chicago. They will be joined in February by David Page from Whitehead and Eric Borwinkel at UT Health Science Center in Houston. And the four of them will comprise the class of 2017 for the council. Next on the agenda are the council minutes from the May Council meeting. Does anyone have any comments or questions about the May Council minutes? And if not, can I have a motion to approve them? A second. All in favor? Any opposed? Thank you. On the open session agenda, I want to draw your attention to the future meetings of the council. If any of you have any, see any scheduled conflicts, please speak to me and probably more importantly speak to Comfort Brown about that. Okay, Eric, I think I'll turn it back to you for the director's report then.